Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France
Elie Azoulay & Eric Mariotte
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
Philippe R. Bauer
Department of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark
Lene Russell
Division of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria
Paul Knoebl
Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James’s Hospital, St James Street, Dublin 8, Ireland
Ignacio Martin-Loeches
Centre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France
Frédéric Pène
Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK
Kathryn Puxty
Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal
Pedro Povoa
NOVA Medical School, New University of Lisbon, Lisbon, Portugal
Pedro Povoa
Center for Clinical Epidemiology and Research, Unit of Clinical Epidemiology, Odense University Hospital Odense, Odense, Denmark
Pedro Povoa
Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
Andreas Barratt-Due
Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain
Jose Garnacho-Montero
King’s College Hospital, London, UK
Julia Wendon
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada
Laveena Munshi
Ghent University Hospital, Ghent, Belgium
Dominique Benoit
Intensive Care in Hematologic and Oncologic Patients, Munich, Germany
Michael von Bergwelt-Baildon
Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany
Michael von Bergwelt-Baildon
Medical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland
Marco Maggiorini
Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA
Andry Van de Louw
Centre National Maladie Rare des Microangiopathies Thrombotiques, Service d’Hématologie, Saint-Antoine Hospital and Paris University, Paris, France
Paul Coppo
Department of Medicine, Ohio State University, Columbus, OH, USA
Spero Cataland
Centre National Maladies Rares des Microangiopathies Thrombotiques, Service d’Hématologie, Lariboisière Hospital and Paris University, Paris, France
Agnès Veyradier